Intrexon to Deploy Novici Biotech GRAMMR Technology for Industrial Applications

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici’s patented GRAMMR technology for high-resolution genetic reassortment (“gene shuffling”).

According to Grace Colón, PhD, President of Intrexon’s Industrial Products Division, Intrexon will be deploying Novici’s GRAMMR technology …

Read More
 

Life Technologies Signs Exclusive License Agreement for DNA Error-Correction Technology from Novici Biotech

CARLSBAD, Calif.–(BUSINESS WIRE)–Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed an exclusive license agreement for ErrASE, a commercially available DNA error-correction kit developed by Novici Biotech LLC to increase accuracy and accelerate the pace of research in the field of synthetic biology.

“A prerequisite of building …

Read More
 
© 2017 Novici Biotech | All Rights Reserved | Privacy Policy
Website Design: Oxford